Clinical Trial Update: Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing biomarker-guided substitution of calcineurin inhibitors in kidney transplantation; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplant | Phase 2 | Status: RECRUITING